Exponent Inc

Exponent Inc(EXPO)股票分析

$71.850

-0.424 (-0.59%)收盤時

Loading chart…
最高
73.460
開盤
72.810
成交量加權均價
72.29
成交量
354.96K
市值
4.85B
最低
71.560
成交金額
25.66M
企業價值/稅息折舊攤銷前利潤(TTM)
25.52

Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.

AI 分析 of Exponent Inc (EXPO)

買進

Exponent Inc is a good buy right now due to its strong financial performance, with a current price of $71.85 and an impressive gross margin of 100%. The company reported a Q2 2026 EPS of $0.60, beating expectations by $0.05, and has raised its revenue guidance for fiscal 2026, anticipating a growth of 9% to 10%. However, the main risk is the forward P/E ratio of 31.55, indicating that the stock may be overvalued if growth does not meet expectations.

分析師評級(4)

上檔空間 +19.00%
持有
1 買進
3 持有
0 賣出
目前: 71.85
最低
81.00
平均
85.50
最高
90.00

UBS

2026-07-31

目標價

$72

中性

JPMorgan

2026-07-31

目標價

$90

增持

JPMorgan

2026-05-15

目標價

$80

增持

UBS

2026-05-01

目標價

$75

中性

JPMorgan

2026-03-26

目標價

$95

增持

估值指標

Exponent Inc(EXPO)目前預期本益比為 31.55,5 年平均預期本益比為 42.63。

預期本益比

低估
5 年均值 P/E
42.63
目前P/E
31.55
高估
51.58
低估
33.68

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
29.72
目前EV/EBITDA
25.52
高估
36.67
低估
22.76

預期股價營收比

低估
5 年均值 P/S
8.50
目前P/S
5.18
高估
10.73
低估
6.26

Alphio AI 對 EXPO 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%EXPO

$68.96

情境價格

基

基準

基準 · 50%EXPO

$67.10

情境價格

悲

悲觀

悲觀 · 25%EXPO

$58.23

情境價格

持有 EXPO 的大戶

R

Roffman Milller Associates Inc

+ 持有EXPO

+2.04%

3個月報酬率

R

Royce & Associates, LP

+ 持有EXPO

-12.48%

3個月報酬率

事件時間軸

2026-07-30 (ET)

17:00:00

Exponent Increases Share Repurchase Authorization by $50M

16:30:00

Exponent Reports Q2 Revenue of $148.86M

16:30:00

Exponent Sees Q3 Adjusted EBITDA at 28%-28.5% of Revenue

16:30:00

Company Raises FY26 Adjusted EBITDA Outlook to 27.8%-28.1%

2026-04-30 (ET)

17:10:00

Exponent's Board Increases Share Repurchase Authority by $50M

資訊

EXPO 常見問題 —— 由 Alphio AI 解答

Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis. It operates in the Industrials sector (SERVICES-MANAGEMENT CONSULTING SERVICES industry).

Exponent Inc is a good buy right now due to its strong financial performance, with a current price of $71.85 and an impressive gross margin of 100%. The company reported a Q2 2026 EPS of $0.60, beating expectations by $0.05, and has raised its revenue guidance for fiscal 2026, anticipating a growth of 9% to 10%. However, the main risk is the forward P/E ratio of 31.55, indicating that the stock may be overvalued if growth does not meet expectations.

4 analysts cover EXPO: 1 rate it Buy, 3 Hold and 0 Sell. The average price target is 85.50.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易